Alnajjar, R., Mostafa, A., Kandeil, A., & Al-Karmalawy, A. A. (2020). Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease. Heliyon, 6(12), e05641. https://doi.org/10.1016/j.heliyon.2020.e05641
Chicago Style (17th ed.) CitationAlnajjar, Radwan, Ahmed Mostafa, Ahmed Kandeil, and Ahmed A. Al-Karmalawy. "Molecular Docking, Molecular Dynamics, and in Vitro Studies Reveal the Potential of Angiotensin II Receptor Blockers to Inhibit the COVID-19 Main Protease." Heliyon 6, no. 12 (2020): e05641. https://doi.org/10.1016/j.heliyon.2020.e05641.
MLA (9th ed.) CitationAlnajjar, Radwan, et al. "Molecular Docking, Molecular Dynamics, and in Vitro Studies Reveal the Potential of Angiotensin II Receptor Blockers to Inhibit the COVID-19 Main Protease." Heliyon, vol. 6, no. 12, 2020, p. e05641, https://doi.org/10.1016/j.heliyon.2020.e05641.